94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details

臨床試験数 : 142 / 薬物数 : 113 - (DrugBank : 37) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 139

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000021411	2016/04/01	01/04/2016	clinical efficacy of oral administration of metronidazole in the treatment of primary sclerosing cholangitis	clinical efficacy of oral administration of metronidazole in the treatment of primary sclerosing cholangitis - clinical efficacy of oral administration of metronidazole in the treatment of PSC	primary sclerosing cholangitis	Patients take metronidazole 250mg orally three times day for 3 weeks.	Keio University, School of Medicine	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	20	Not applicable	Japan
2	NCT03069976 (ClinicalTrials.gov)	January 2016	28/2/2017	Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children	Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Modification With Antibiotics in Children	Primary Sclerosing Cholangitis;Autoimmune Hepatitis;Overlap Syndrome	Drug: Metronidazole	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Recruiting	3 Years	25 Years	All	20	N/A	Belgium
3	NCT01085760 (ClinicalTrials.gov)	February 2010	10/3/2010	A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis	A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	Drug: Vancomycin;Drug: Metronidazole	Mayo Clinic	PSC Partners Seeking a Cure Foundation	Completed	18 Years	75 Years	All	35	Phase 1	United States